About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [2,257 citations: 101–200 of 1,977 articles]

Articles published in International Journal of Alzheimer’s Disease have been cited 2,257 times. The following is a list of the 1,977 articles that have cited the articles published in International Journal of Alzheimer’s Disease.

  • David P. Marciano, Mi Ra Chang, Cesar A. Corzo, Devrishi Goswami, Vinh Q. Lam, Bruce D. Pascal, and Patrick R. Griffin, “The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs,” Cell Metabolism, 2014. View at Publisher · View at Google Scholar
  • H. Ulrich, J. Bocsi, T. Glaser, and A. Tárnok, “Cytometry in the brain: studying differentiation to diagnostic applications in brain disease and regeneration therapy,” Cell Proliferation, vol. 47, no. 1, pp. 12–19, 2014. View at Publisher · View at Google Scholar
  • Xiaqin Sun, Yu Wu, Mingxue Gu, and Yan Zhang, “miR-342-5p Decreases Ankyrin G Levels in Alzheimer's Disease Transgenic Mouse Models,” Cell Reports, vol. 6, no. 2, pp. 264–270, 2014. View at Publisher · View at Google Scholar
  • Delphine Meffre, Julien Grenier, Sophie Bernard, Francoise Courtin, Todor Dudev, Ghjuvan'Ghjacumu Shackleford, Mehrnaz Jafarian-Tehrani, and Charbel Massaad, “Wnt and lithium: a common destiny in the therapy of nervous system pathologies?,” Cellular and Molecular Life Sciences, vol. 71, no. 7, pp. 1123–1148, 2014. View at Publisher · View at Google Scholar
  • Chuan Tian, Ruixin Zhu, Lixin Zhu, Tianyi Qiu, and Zhiwei Cao, “Potassium Channels: Structures, Diseases, and Modulators,” Chemical Biology & Drug Design, vol. 83, no. 1, pp. 1–26, 2014. View at Publisher · View at Google Scholar
  • A. Grubman, S. A. James, J. James, C. Duncan, I. Volitakis, J. L. Hickey, P. J. Crouch, P. S. Donnelly, K. M. Kanninen, J. R. Liddell, S. L. Cotman, M. D. de Jonge, and A. R. White, “X-ray fluorescence imaging reveals subcellular biometal disturbances in a childhood neurodegenerative disorder,” Chemical Science, vol. 5, no. 6, pp. 2503–2516, 2014. View at Publisher · View at Google Scholar
  • Sharbari Palmal, Amit Ranjan Maity, Brijesh Kumar Singh, Sreetama Basu, Nihar R. Jana, and Nikhil R. Jana, “Inhibition of Amyloid Fibril Growth and Dissolution of Amyloid Fibrils by Curcumin-Gold Nanoparticles,” Chemistry-A European Journal, vol. 20, no. 20, pp. 6184–6191, 2014. View at Publisher · View at Google Scholar
  • Irum Naureen, Kh. A. Irfan Waheed, Ahsen W. Rathore, Suresh Victor, Conor Mallucci, John R. Goodden, Shahid N. Chohan, and Jaleel A. Miyan, “Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: inflammatory cytokines,” Childs Nervous System, vol. 30, no. 7, pp. 1155–1164, 2014. View at Publisher · View at Google Scholar
  • Antonella Mandas, and Sandra Dessì, “Mononuclear Cells in Dementia,” Clinica Chimica Acta, 2014. View at Publisher · View at Google Scholar
  • Constance Delaby, Audrey Gabelle, Philippe Meynier, Vincent Loubiere, Jerome Vialaret, Laurent Tiers, Jacques Ducos, Christophe Hirtz, and Sylvain Lehmann, “Development and validation of dried matrix spot sampling for the quantitative determination of amyloid beta peptides in cerebrospinal fluid,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 5, pp. 649–655, 2014. View at Publisher · View at Google Scholar
  • Paulo Afonso Medeiros Kanda, Lucas R. Trambaiolli, Ana C. Lorena, Francisco J. Fraga, Luis Fernando I. Basile, Ricardo Nitrini, and Renato Anghinah, “Clinician's Road Map to Wavelet EEG as an Alzheimer's disease Biomarker,” Clinical Eeg and Neuroscience, vol. 45, no. 2, pp. 104–112, 2014. View at Publisher · View at Google Scholar
  • Jessica M. Foley, and Andrew L. Heck, “Neurocognitive Disorders in Aging: A Primer on DSM-5 Changes and Framework for Application to Practice,” Clinical Gerontologist, vol. 37, no. 4, pp. 317–346, 2014. View at Publisher · View at Google Scholar
  • Anaick Perrochon, and Gilles Kemoun, “The Walking Trail-Making Test is an early detection tool for mild cognitive impairment,” Clinical Interventions in Aging, vol. 9, pp. 111–119, 2014. View at Publisher · View at Google Scholar
  • Chong-Juan Wei, Yan Cheng, Yun Zhang, Feng Sun, Wei-san Zhang, and Ming-yi Zhang, “Risk factors for dementia in highly educated elderly people in Tianjin, China,” Clinical Neurology and Neurosurgery, vol. 122, pp. 4–8, 2014. View at Publisher · View at Google Scholar
  • Antonio J. Ibáñez-Molina, Sergio Iglesias-Parro, María F. Soriano, and José I. Aznarte, “Multiscale Lempel–Ziv complexity for EEG measures,” Clinical Neurophysiology, 2014. View at Publisher · View at Google Scholar
  • Shuo Zhang, Nadja Smailagic, Chris Hyde, Anna H. Noel-Storr, Yemisi Takwoingi, Rupert McShane, and Juan Feng, “11C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI),” Cochrane Database of Systematic Reviews, no. 7, 2014. View at Publisher · View at Google Scholar
  • Joseph McBride, Xiaopeng Zhao, Nancy Munro, Charles Smith, Gregory Jicha, Lee Hively, Lucas Broster, Frederick A. Schmitt, Richard J. Kryscio, and Yang Jiang, “Spectral and Complexity Analysis of Scalp EEG Characteristics for Mild Cognitive Impairment and Early Alzheimer's Disease,” Computer Methods and Programs in Biomedicine, 2014. View at Publisher · View at Google Scholar
  • Gaetano Malgieri, and Giuseppe Grasso, “The clearance of misfolded proteins in neurodegenerative diseases by zinc metalloproteases: An inorganic perspective,” Coordination Chemistry Reviews, vol. 260, pp. 139–155, 2014. View at Publisher · View at Google Scholar
  • Javier de Cristobal, Luis Garcia-Garcia, Mercedes Delgado, Miguel A. Pozo, and Miguel Medina, “A Longitudinal FDG-PET Study of Transgenic Mice Overexpressing GSK-3 beta in the Brain,” Current Alzheimer Research, vol. 11, no. 2, pp. 175–181, 2014. View at Publisher · View at Google Scholar
  • Sana Suri, Anya Topiwala, Clare E. Mackay, Klaus P. Ebmeier, and Nicola Filippini, “Using Structural and Diffusion Magnetic Resonance Imaging To Differentiate the Dementias,” Current Neurology and Neuroscience Reports, vol. 14, no. 9, 2014. View at Publisher · View at Google Scholar
  • Angel Agis-Torres, Monica Soellhuber, Maria Fernandez, and J. M. Sanchez-Montero, “Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease,” Current Neuropharmacology, vol. 12, no. 1, pp. 2–36, 2014. View at Publisher · View at Google Scholar
  • Kristine B. Walhovd, Christian K. Tamnes, and Anders M. Fjell, “Brain structural maturation and the foundations of cognitive behavioral development,” Current Opinion in Neurology, vol. 27, no. 2, pp. 176–184, 2014. View at Publisher · View at Google Scholar
  • Francesco Panza, Giancarlo Logroscino, Bruno P. Imbimbo, and Vincenzo Solfrizzi, “Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?,” Current Opinion in Psychiatry, vol. 27, no. 2, pp. 128–137, 2014. View at Publisher · View at Google Scholar
  • Samantha Holden, “Treatment of Psychosis and Dementia in Parkinson's Disease,” Current Treatment Options in Neurology, vol. 16, no. 3, 2014. View at Publisher · View at Google Scholar
  • Tushar S. Basu Baul, Sajal Kundu, Anthony Linden, Nune Raviprakash, Sunil K. Manna, and M. Fatima C. Guedes da Silva, “Synthesis and characterization of some water soluble Zn(II) complexes with (E)-N-(pyridin-2-ylmethylene)arylamines that regulate tumour cell death by interacting with DNA,” Dalton Transactions, vol. 43, no. 3, pp. 1191–1202, 2014. View at Publisher · View at Google Scholar
  • Suvarna Alladi, Mekala Shailaja, Kandadai Rukmini Mridula, Chowdary Arikaudi Haritha, Nallapareddy Kavitha, Shujath Ali Khan, Gollahalli Divyaraj, and Subhash Kaul, “Mild Cognitive Impairment: Clinical and Imaging Profile in a Memory Clinic Setting in India,” Dementia and Geriatric Cognitive Disorders, vol. 37, no. 1-2, pp. 113–124, 2014. View at Publisher · View at Google Scholar
  • Erin L. Abner, Peter T. Nelson, Frederick A. Schmitt, Steven R. Browning, David W. Fardo, Lijie Wan, Gregory A. Jicha, Gregory E. Cooper, Charles D. Smith, Allison M. Caban-Holt, Linda J. Van Eldik, and Richard J. Kryscio, “Self-Reported Head Injury and Risk of Late-Life Impairment and AD Pathology in an AD Center Cohort,” Dementia and Geriatric Cognitive Disorders, vol. 37, no. 5-6, pp. 294–306, 2014. View at Publisher · View at Google Scholar
  • Jakub Kazmierski, Andrzej Banys, Joanna Latek, Julius Bourke, Ryszard Jaszewski, Tomasz Sobow, and Iwona Kloszewska, “Mild Cognitive Impairment with Associated Inflammatory and Cortisol Alterations as Independent Risk Factor for Postoperative Delirium,” Dementia and Geriatric Cognitive Disorders, vol. 38, no. 1-2, pp. 65–78, 2014. View at Publisher · View at Google Scholar
  • Andre Kleinridders, Heather A. Ferris, Weikang Cai, and C. Ronald Kahn, “Insulin Action in Brain Regulates Systemic Metabolism and Brain Function,” Diabetes, vol. 63, no. 7, pp. 2232–2243, 2014. View at Publisher · View at Google Scholar
  • Walker S. Jackson, “Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein,” Disease Models & Mechanisms, vol. 7, no. 1, pp. 21–29, 2014. View at Publisher · View at Google Scholar
  • Mansour Akbari, Guido Keijzers, Scott Maynard, Morten Scheibye-Knudsen, Claus Desler, Ian D. Hickson, and Vilhelm A. Bohr, “Overexpression of DNA ligase III in mitochondria protects cells against oxidative stress and improves mitochondrial DNA base excision repair,” Dna Repair, vol. 16, pp. 44–53, 2014. View at Publisher · View at Google Scholar
  • Dante J. Marciani, “New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies,” Drug Discovery Today, vol. 19, no. 7, pp. 912–920, 2014. View at Publisher · View at Google Scholar
  • Emily Ann Carlson, Valasani Koteswara Rao, and Shirley ShiDu Yan, “From a cell's viewpoint: targeting mitochondria in Alzheimer's disease,” Drug Discovery Today: Therapeutic Strategies, 2014. View at Publisher · View at Google Scholar
  • Jennifer L Stamos, Matthew Ling-Hon Chu, Michael D Enos, Niket Shah, and William I Weis, “Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6,” eLife, vol. 3, 2014. View at Publisher · View at Google Scholar
  • Jennifer L. Stamos, Matthew Ling-Hon Chu, Michael D. Enos, Niket Shah, and William I. Weis, “Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6,” Elife, vol. 3, 2014. View at Publisher · View at Google Scholar
  • Shih-Wei Lai, Cheng-Li Lin, and Kuan-Fu Liao, “Cataract may be a non-memory feature of Alzheimer's disease in older people,” European Journal of Epidemiology, vol. 29, no. 6, pp. 405–409, 2014. View at Publisher · View at Google Scholar
  • Yingling Wei, Ai-Yun Peng, Bo Wang, Lin Ma, Guoping Peng, Yidan Du, and Jingming Tang, “Synthesis and biological evaluation of phosphorylated flavonoids as potent and selective inhibitors of cholesterol esterase,” European Journal of Medicinal Chemistry, vol. 74, pp. 751–758, 2014. View at Publisher · View at Google Scholar
  • Su-Yi Li, Xiao-Bing Wang, and Ling-Yi Kong, “Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease,” European Journal of Medicinal Chemistry, vol. 71, pp. 36–45, 2014. View at Publisher · View at Google Scholar
  • Frederic Pin, Johnny Vercouillie, Aziz Ouach, Sylvie Mavel, Zuhal Gulhan, Gabrielle Chicheri, Christian Jarry, Stephane Massip, Jean-Bernard Deloye, Denis Guilloteau, Franck Suzenet, Sylvie Chalon, and Sylvain Routier, “Design of alpha 7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [F-18] quinuclidine derivative,” European Journal of Medicinal Chemistry, vol. 82, pp. 214–224, 2014. View at Publisher · View at Google Scholar
  • X.-L. Bu, X.-Q. Yao, S.-S. Jiao, F. Zeng, Y.-H. Liu, Y. Xiang, C.-R. Liang, Q.-H. Wang, X. Wang, H.-Y. Cao, X. Yi, B. Deng, C.-H. Liu, J. Xu, L.-L. Zhang, C.-Y. Gao, Z.-Q. Xu, M. Zhang, L. Wang, X.-L. Tan, X. Xu, H.-D. Zhou, and Y.-J. Wang, “A study on the association between infectious burden and Alzheimer's disease,” European Journal of Neurology, 2014. View at Publisher · View at Google Scholar
  • Eric C. Miller, and Peter J. Teravskis, “Tau acts as a mediator for Alzheimer's disease-related synaptic deficits,” European Journal of Neuroscience, vol. 39, no. 7, pp. 1202–1213, 2014. View at Publisher · View at Google Scholar
  • Eric C. Miller, Peter J. Teravskis, Benjamin W. Dummer, Xiaohui Zhao, Richard L. Huganir, and Dezhi Liao, “Tau phosphorylation and tau mislocalization mediate soluble A beta oligomer-induced AMPA glutamate receptor signaling deficits,” European Journal of Neuroscience, vol. 39, no. 7, pp. 1214–1224, 2014. View at Publisher · View at Google Scholar
  • Hervé Maurin, Benoit Lechat, Peter Borghgraef, Herman Devijver, Tomasz Jaworski, and Fred Van Leuven, “Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β,” European Journal of Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Xiaoshuang Wang, Jie Li, and Guicheng Dong, “The endogenous substrates of brain CYP2D,” European Journal of Pharmacology, vol. 724, pp. 211–218, 2014. View at Publisher · View at Google Scholar
  • Atish Prakash, and Anil Kumar, “Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer's disease,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Salvatore Caratozzolo, Maddalena Riva, Barbara Vicini Chilovi, Erica Cerea, Giulia Mombelli, Alessandro Padovani, and Luca Rozzini, “Prestroke Dementia: Characteristics and Clinical Features in Consecutive Series of Patients,” European Neurology, vol. 71, no. 3-4, pp. 148–154, 2014. View at Publisher · View at Google Scholar
  • Zeynel Baran, Banu Cangoz, and Erguvan T. Ozel-Kizil, “The Impact of Aging and Alzheimer's Disease on Emotional Enhancement of Memory,” European Neurology, vol. 72, no. 1-2, pp. 30–37, 2014. View at Publisher · View at Google Scholar
  • Robert L. Gannon, David A. Garcia, and Mark J. Millan, “Effects of systemically applied nAChR alpha 7 agonists and antagonists on light-induced phase shifts of hamster circadian activity rhythms,” European Neuropsychopharmacology, vol. 24, no. 6, pp. 964–973, 2014. View at Publisher · View at Google Scholar
  • Lior Greenbaum, Ramit Ravona Springer, Michael W. Lutz, Anthony Heymann, Irit Lubitz, Itzik Cooper, Efrat Kravitz, Mary Sano, Allen D. Roses, Jeremy M Silverman, Ann M. Saunders, and Michal Schnaider Beeri, “The TOMM40 poly-T rs10542523 variant Is associated with cognitive performance among non-demented elderly with type 2 diabetes,” European Neuropsychopharmacology, 2014. View at Publisher · View at Google Scholar
  • Xiang-Hong Zeng, Qian-Qian Li, Qian Xu, Fang Li, and Cun-Zhi Liu, “Acupuncture Mechanism and Redox Equilibrium,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Hidetoshi Watari, Yutaka Shimada, and Chihiro Tohda, “New Treatment for Alzheimer’s Disease, Kamikihito, Reverses Amyloid--Induced Progression of Tau Phosphorylation and Axonal Atrophy,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Lihong Zhu, Wei Bi, Dan Lu, Chanjuan Zhang, Xiaoming Shu, and Daxiang Lu, “Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-kappa B, mitogen-activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells,” Experimental and Therapeutic Medicine, vol. 7, no. 5, pp. 1065–1070, 2014. View at Publisher · View at Google Scholar
  • Elizabeth J. Horn, and Helen M. Moore, “Overcoming challenges in the acquisition of biospecimens for rare diseases,” Expert Opinion on Orphan Drugs, vol. 2, no. 1, pp. 1–4, 2014. View at Publisher · View at Google Scholar
  • Francesco Panza, Vincenzo Solfrizzi, Bruno P. Imbimbo, Rosanna Tortelli, Andrea Santamato, and Giancarlo Logroscino, “Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward,” Expert Review of Clinical Immunology, vol. 10, no. 3, pp. 405–419, 2014. View at Publisher · View at Google Scholar
  • Diane Stephenson, “Alzheimer's disease from researcher to caregiver: a personal journey and call to action,” Expert Review of Neurotherapeutics, vol. 14, no. 5, pp. 465–467, 2014. View at Publisher · View at Google Scholar
  • Sven Reinhardt, Florian Schuck, Sven Groesgen, Matthias Riemenschneider, Tobias Hartmann, Rolf Postina, Marcus Grimm, and Kristina Endres, “Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease,” Faseb Journal, vol. 28, no. 2, pp. 978–997, 2014. View at Publisher · View at Google Scholar
  • Tanja Larsen, Yayoi Yoshimura, Bjørn G.R. Voldborg, Giuseppe Cazzamali, Nicolai V. Bovin, Ulrika Westerlind, Monica M. Palcic, and Jørgen J. Leisner, “Human chitotriosidase CHIT1 cross reacts with mammalian-like substrates,” FEBS Letters, 2014. View at Publisher · View at Google Scholar
  • Huong T.T. Phan, Mun’delanji C. Vestergaard, KeangOk Baek, Naofumi Shimokawa, and Masahiro Takagi, “Localization of amyloid beta (Aβ1-42) protofibrils in membrane lateral compartments: effect of cholesterol and 7-ketocholesterol,” FEBS Letters, 2014. View at Publisher · View at Google Scholar
  • Boguslaw Lipinski, and Etheresia Pretorius, “Iron-induced fibrin formation may explain vascular pathology in Alzheimer's disease,” Folia Neuropathologica, vol. 52, no. 2, pp. 205–205, 2014. View at Publisher · View at Google Scholar
  • Jia-Ching Wu, Mei-Ling Tsai, Ching-Shu Lai, Ying-Jan Wang, Chi-Tang Ho, and Min-Hsiung Pan, “Chemopreventative effects of tetrahydrocurcumin on human diseases,” Food & Function, vol. 5, no. 1, pp. 12, 2014. View at Publisher · View at Google Scholar
  • M.S. Allagui, A. Feriani, M. Saoudi, R. Badraoui, Z. Bouoni, R. Nciri, J.C. Murat, and A. Elfeki, “Effects of melatonin on aluminium-induced neurobehavioral and neurochemical changes in aging rats,” Food and Chemical Toxicology, 2014. View at Publisher · View at Google Scholar
  • Celeste Di Paolo, Ingrid Reverte, Maria Teresa Colomina, Jose L. Domingo, and Mercedes Gomez, “Chronic exposure to aluminum and melatonin through the diet: Neurobehavioral effects in a transgenic mouse model of Alzheimer disease,” Food and Chemical Toxicology, vol. 69, pp. 320–329, 2014. View at Publisher · View at Google Scholar
  • Celeste Di Paolo, Maria Cabre, Jose L. Domingo, and Mercedes Gomez, “Melatonin does not modify the concentration of different metals in A beta PP transgenic mice,” Food and Chemical Toxicology, vol. 70, pp. 252–259, 2014. View at Publisher · View at Google Scholar
  • X. Meng, M. Wang, X. Wang, G. Sun, J. Ye, H. Xu, and X. Sun, “Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways,” Free Radical Research, vol. 48, no. 7, pp. 823–838, 2014. View at Publisher · View at Google Scholar
  • Zhijie Bian, Qiuli Li, Lei Wang, Chengbiao Lu, Shimin Yin, and Xiaoli Li, “Relative power and coherence of EEG series are related to amnestic mild cognitive impairment in diabetes,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Haruna Tamano, “Cognitive decline due to excess synaptic Zn2+ signaling in the hippocampus,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Jan Klohs, Markus Rudin, Derya R. Shimshek, and Nicolau Beckmann, “Imaging of cerebrovascular pathology in animal models of Alzheimer's disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Maria Cotelli, Rosa Manenti, Michela Brambilla, Michela Petesi, Sandra Rosini, Clarissa Ferrari, Orazio Zanetti, and Carlo Miniussi, “Anodal tDCS during face-name associations memory training in Alzheimer's patients,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Rui Li, Xinyi Zhu, Shufei Yin, Yanan Niu, Zhiwei Zheng, Xin Huang, Baoxi Wang, and Juan Li, “Multimodal intervention in older adults improves resting-state functional connectivity between the medial prefrontal cortex and medial temporal lobe†,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Daniel Ferreira, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio Sarría, and Pedro Serrano-Aguilar, “Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Raymundo Cassani, Tiago H. Falk, Francisco J. Fraga, Paulo A. M. Kanda, and Renato Anghinah, “The effects of automated artifact removal algorithms on electroencephalography-based Alzheimer's disease diagnosis,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • J. Carson Smith, Kristy A. Nielson, John L. Woodard, Michael Seidenberg, Sally Durgerian, Kathleen E. Hazlett, Christina M. Figueroa, Cassandra C. Kandah, Christina D. Kay, Monica A. Matthews, and Stephen M. Rao, “Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Mitsuru Shinohara, Naoyuki Sato, Munehisa Shimamura, Hitomi Kurinami, Toshimitsu Hamasaki, Amarnath Chatterjee, Hiromi Rakugi, and Ryuichi Morishita, “Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Yvonne Bouter, Tim Kacprowski, Robert Weissmann, Katharina Dietrich, Henning Borgers, Andreas Brauß, Christian Sperling, Oliver Wirths, Mario Albrecht, Lars R. Jensen, Andreas W. Kuss, and Thomas A. Bayer, “Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • George J. Brewer, “Alzheimer's disease causation by copper toxicity and treatment with zinc,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Alberto Granzotto, and Palol Zatta, “Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • He Xu, David I. Finkelstein, and Paul A. Adlard, “Interactions of metals and Apolipoprotein E in Alzheimer’s disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Carlos M. Opazo, Mark A. Greenough, and Ashley I. Bush, “Copper: from neurotransmission to neuroproteostasis,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Sylvia Villeneuve, Diane Brisson, Natalie L. Marchant, and Daniel Gaudet, “The potential applications of Apolipoprotein E in personalized medicine,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Guendalina Olivero, Massimo Grilli, Jiayang Chen, Stefania Preda, Elisa Mura, Stefano Govoni, and Mario Marchi, “Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Davide V. Moretti, Giovanni B. Frisoni, Giuliano Binetti, and Orazio Zanetti, “Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer’s disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Paul A. Adlard, Qiao-Xin Li, Catriona McLean, Colin L. Masters, Ashley I. Bush, Michelle Fodero-Tavoletti, Victor Villemagne, and Kevin J. Barnham, “β-amyloid in biological samples: not all Aβ detection methods are created equal,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Nicole T. Watt, Heledd H. Griffiths, and Nigel M. Hooper, “Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease,” Frontiers in Cell and Developmental Biology, vol. 2, 2014. View at Publisher · View at Google Scholar
  • Inelia Morales, Leonardo Guzman-Martinez, Cristobal Cerda-Troncoso, Gonzalo A. Farias, and Ricardo B. Maccioni, “Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Ines do Carmo G. Goncalves, “The role of rniRNA in motor neuron disease,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Marie Violet, Lucie Delattre, Meryem Tardivel, Audrey Sultan, Alban Chauderlier, Raphaelle Caillierez, Smail Talahari, Fabrice Nesslany, Bruno Lefebvre, Eliette Bonnefoy, Luc Buée, and Marie-Christine Galas, “A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Aleksandra Maruszak, and Sandrine Thuret, “Why looking at the whole hippocampus is not enough - a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Inelia Morales, Leonardo Guzmán-Martínez, Cristóbal Cerda-Troncoso, Gonzalo A. Farías, and Ricardo B. Maccioni, “Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Dora Brites, and Ana R. Vaz, “Microglia centered pathogenesis in ALS: insights in cell interconnectivity,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Mauricio O. Nava-Mesa, Lydia Jimenez-Diaz, Javier Yajeya, and Juan D. Navarro-Lopez, “GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Roger Ferreira, Starlee Lively, and Lyanne C. Schlichter, “IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Roger Ferreira, Starlee Lively, and Lyanne C. Schlichter, “IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3.1 current and its contribution to migration of alternative-activated microglia,” Frontiers in Cellular Neuroscience, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Mohammed Akli Ayoub, Julien Trebaux, Julie Vallaghe, Fabienne Charrier-Savournin, Khaled Al-Hosaini, Arturo Gonzalez Moya, Jean-Philippe Pin, Kevin D. G. Pfleger, and Eric Trinquet, “Homogeneous Time-Resolved Fluorescence-Based Assay to Monitor Extracellular Signal-Regulated Kinase Signaling in a High-Throughput Format,” Frontiers in Endocrinology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Jonathan Janssens, Harmonie Etienne, Sherif Idriss, Abdelkrim Azmi, Bronwen Martin, and Stuart Maudsley, “Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System,” Frontiers in Endocrinology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Dubravka Vučićević, Heinrich Schrewe, and Ulf A. Ørom, “Molecular mechanisms of long ncRNAs in neurological disorders,” Frontiers in Genetics, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Beena M. Kadakkuzha, Xin-An Liu, Maria Narvaez, Alexandra Kaye, Komolitdin Akhmedov, and Sathyanarayanan V. Puthanveettil, “Asymmetric localization of natural antisense RNA of neuropeptide sensorin in Aplysia sensory neurons during aging and activity,” Frontiers in Genetics, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Brian S. Clark, and Seth Blackshaw, “Long non-coding RNA-dependent transcriptional regulation in neuronal development and disease,” Frontiers in Genetics, vol. 5, 2014. View at Publisher · View at Google Scholar
  • María Llorens-Marítin, Jerónimo Jurado, Félix Hernández, and Jesús Ávila, “GSK-3β, a pivotal kinase in Alzheimer disease,” Frontiers in Molecular Neuroscience, vol. 7, 2014. View at Publisher · View at Google Scholar
  • Rena Li, and Meharvan Singh, “Sex differences in cognitive impairment and Alzheimer's disease,” Frontiers in Neuroendocrinology, vol. 35, no. 3, pp. 385–403, 2014. View at Publisher · View at Google Scholar
  • Pradeep Reddy Raamana, Howard Rosen, Bruce Miller, Michael W. Weiner, Lei Wang, and Mirza Faisal Beg, “Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls,” Frontiers in Neurology, vol. 5, 2014. View at Publisher · View at Google Scholar